| 2026-03-11 |
详情>>
股本变动：
变动后总股本10015.32万股
|
| 2026-03-11 |
详情>>
业绩披露：
2025年年报每股收益-0.37美元,归母净利润-3712.1万美元,同比去年增长-152.09%
|
| 2026-03-11 |
财报披露：
美东时间 2026-03-11 盘前发布财报
|
| 2026-02-27 |
详情>>
内部人交易：
Archer James Bradley等共交易31笔
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.22美元,归母净利润-2218.7万美元,同比去年增长-137.76%
|
| 2025-08-18 |
股东大会：
将于2025-09-12召开股东大会
会议内容 ▼▲
- 1.To consider and, if deemed advisable, to pass, with or without variation, a special resolution (the “Arrangement Resolution”), the full text of which is set forth in Appendix C attached to the accompanying management proxy circular (the “Circular”), approving a statutory plan of arrangement (the “Arrangement”) under Chapter XVI – Division II of the Business Corporations Act (Québec) (the “QBCA”) involving the Corporation and CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC ( “Future Pak”), as more particularly described in the Circular;
2.To transact any other business as may properly come before the Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-0.22美元,归母净利润-2139.2万美元,同比去年增长-155.18%
|
| 2025-05-19 |
详情>>
业绩披露：
2025年一季报每股收益-0.07美元,归母净利润-646.1万美元,同比去年增长-131.7%
|
| 2025-05-02 |
股东大会：
将于2025-05-29召开股东大会
会议内容 ▼▲
- 1.To receive the consolidated financial statements for the fiscal year ended November 30, 2024, as well as the auditors’ report thereon;
2.To elect directors for the ensuing year;
3.To appoint auditors for the ensuing year and authorize the directors to set their compensation;
4.To consider and, if deemed advisable, to pass Resolution 2025-1 (the text of which is attached as Appendix “A” to the accompanying management proxy circular), with or without amendments, approving the creation of an omnibus long-term incentive compensation plan providing for the issuance of equity-linked securities, the whole as described in the accompanying management proxy circular;
5.To transact such other business as may properly come before the Meeting.
|
| 2025-04-08 |
股东大会：
将于2025-05-22召开股东大会
会议内容 ▼▲
- 1.Elect as directors the nominees listed in this proxy statement to serve until the 2026 annual meeting of stockholders or until their successors are duly elected and qualified
2.Ratify the appointment of ernst & young llp as our independent public accounting firm
3.Approve, on an advisory basis, the compensation of our named executive officers
4.Approve the second amendment to the target hospitality corp. 2019 incentive award plan, as amended
|
| 2025-03-26 |
详情>>
业绩披露：
2024年年报每股收益0.71美元,归母净利润7126.50万美元,同比去年增长-56.71%
|
| 2025-03-26 |
详情>>
业绩披露：
2022年年报每股收益0.76美元,归母净利润7393.90万美元,同比去年增长1715.80%
|
| 2024-11-12 |
详情>>
业绩披露：
2023年三季报(累计)每股收益1.34美元,归母净利润1.34亿美元,同比去年增长216.40%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.58美元,归母净利润5876.30万美元,同比去年增长-56.16%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益0.39美元,归母净利润3876.90万美元,同比去年增长-57.06%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益0.20美元,归母净利润2038.30万美元,同比去年增长-49.19%
|
| 2024-04-10 |
股东大会：
将于2024-05-23召开股东大会
会议内容 ▼▲
- 1.Elect as directors the nominees listed in this proxy statement to serve until the 2025 annual meeting of stockholders or until their successors are duly elected and qualified.
2.Ratify the appointment of ernst & young llp as our independent public accounting firm.
3.Approve or disapprove, by advisory vote, the compensation of our named executive officers.
4.Determine the frequency of the advisory vote on the compensation of our named executive officers.
|
| 2024-03-13 |
详情>>
业绩披露：
2023年年报每股收益1.71美元,归母净利润1.65亿美元,同比去年增长122.67%
|
| 2023-04-05 |
股东大会：
将于2023-05-18召开股东大会
会议内容 ▼▲
- 1.Elect as directors the nominees listed in this proxy statement to serve until the 2024 annual meeting of stockholders or until their successors are duly elected and qualified
2.Ratify the appointment of ernst & young llp as our independent public accounting firm
|
| 2022-04-07 |
股东大会：
将于2022-05-19召开股东大会
会议内容 ▼▲
- 1.Elect as directors the three class i nominees listed in this proxy statement to serve until the 2025 annual meeting of stockholders or until their successors are duly elected and qualified
2.Approve amendments to the amended and restated certificate of incorporation (“A&R charter”) of the company to declassify the board of directors
3.Amend the target hospitality corp. 2019 incentive award plan (“incentive plan”) solely to increase the number of shares authorized for issuance under the incentive plan
4.Ratify the appointment of Ernst & Young LLP as our independent public accounting firm
|
| 2022-03-30 |
复牌提示：
2022-03-29 09:36:46 停牌，复牌日期 2022-03-29 09:46:46
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-06 |
股东大会：
将于2021-05-18召开股东大会
会议内容 ▼▲
- 1.Elect as directors the three Class III nominees listed in this proxy statement to serve until the 2024 annual meeting of stockholders or until their successors are duly elected and qualified
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021
|
| 2020-04-06 |
股东大会：
将于2020-05-20召开股东大会
会议内容 ▼▲
- 1.Elect as directors the two Class II nominees listed in this proxy statement to serve until the 2023 annual meeting of stockholders or until their successors are duly elected and qualified
2.Elect as directors the two Class II nominees listed in this proxy statement to serve until the 2023 annual meeting of stockholders or until their successors are duly elected and qualified
3.To consider such other business as may properly come before the meeting or any adjournment or postponement thereof
|
| 2019-05-02 |
股东大会：
将于2019-06-21召开股东大会
会议内容 ▼▲
- 1.Elect as directors the three Class I nominees listed in this proxy statement to serve until the 2022 annual meeting of stockholders or until their successors are duly elected and qualified
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019
3.To consider such other business as may properly come before the meeting or any adjournment or postponement thereof
|